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It has been known for many years that some compounds produced by edible mushrooms encompass
anticancer activities. Most of production methods were based on cultivation of mushroom in solid
medium. In the present study Pleurotus ostreatus mycelia were grown in submerged culture. The culti-
vation of fungal cells in submerged culture resulted in higher growth rate with better control of pro-
duction process. The bioactive polysaccharides (both intracellular and extracellular) were extracted
from culture by solvent repeated precipitation. The polysaccharide structure was determined by exam-
ining NMR, IR spectra and the primary structure of the polysaccharide was mainly glucan. The 13C
NMR spectral pattern indicated the polysaccharides are highly branched with mainly 1→3 and 1→6
linkage. The results of in vitro anti cancer studies demonstrate that this type of polysaccharides pos-
sesses anticancer activity against human oesophageal cancer cell line. Moreover, in the course of in vit-
ro studies, mushroom polysaccharides showed anti-tumour activity and also considered to be biologi-
cal response modifier because of their mechanism of action through stimulation of the immune
system. The polysaccharide activity is especially beneficial in clinics when used as an adjuvant with
chemotherapy to decrease its side effect. This work describes production process of anti cancer com-
pound(s) by mushrooms and suitable for pharmaceutical industries.
1. Introduction
Mushrooms have been eaten and appreciated for their flavour, economical
and ecological values, and medicinal properties for many years. Mushrooms
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are abundant sources of a wide range of useful natural products with biologi-
cal activities (Lorenzen and Anke, 1998; Wasser, 2002; Mao and Zhong,
2004). Much interest in biotechnological methods for the production of mi-
crobial polysaccharides has been generated for applications in pharmaceuti-
cals industries (Kuo et al., 1996, Liu et al., 1997). However, most of polysac-
charides with various physiological activities frequently originated from fungi
especially mushrooms. Moreover, mushroom has some other medical applica-
tions for the treatment of diseases such as hypoglycaemia (Yuan et al., 1998;
Kiho et al., 1994; Yang et al., 2002). In spite of most researches deal with
polysaccharides extracted from the fruiting bodies, other has studied extracel-
lular polysaccharides (EPS). The EPS term is used to describe polysaccha-
rides found outside the cell or which are free within the surrounding medium.
The production of EPS from mushroom in submerged culture is interesting
because of several advantages over the conventional method using fruit body
extraction. In submerged culture, the growth rate of fungal cell is higher and
the product requires only relatively simple purification steps (Cavazzoni and
Adami, 1992; Jong and Birmingham, 1992). Moreover, some wild mush-
rooms are not able to be cultivated in traditional way and able only to grow in
submerged culture using enriched culture medium under controlled cultiva-
tion conditions. Recent studies of EPS production from mushrooms demon-
strated their significant anticancer activity (Kim et al., 2001; Ng 1998).
Pleurotus ostreatus is an edible mushroom belonging to the family Basid-
iomycetes. This fungi is one of the five main edible fungi cultivated world-
wide and display easy adaptation to different growth conditions in submerged
cultures (Marquez-Rocha et al., 1999; Bae et al., 2000; Rosado et al., 2003).
In this context, the current study reports some results for cell growth and
EPS production kinetics during cultivation of P. ostreatus in stirred tank
bioreactor. The produced polysacchariede was extracted and completely
identified. Further studies of its anticancer activity were also done.
2. Materials and Methods
2.1. Microorganism and cultivation conditions
Basidiomycetes fungus Pleurotus ostreatus NRRL 366 was kindly provided by
the agriculture research service Peoria, USA. The strain was maintained and
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reactivated monthly in Petri dishes containing a sterile solid potato dextrose
agar medium (PDA, Oxoid, UK). Cells were incubated at 28°C for 14 days
and stored in a refrigerator at 5°C.
2.2. Medium for cell growth and EPS production in bioreactor
The medium used in bioreactor experiments was composed of [g l-1]: glucose,
20.0; KH2PO4, 0.46; K2HPO4, 1.0; MgSO4×7H2O, 0.5; peptone, 2.0 and
yeast extract, 2.0. Glucose was sterilized separately and added to the cultiva-
tion medium before inoculation; pH was adjusted to 5.5 after sterilization.
2.3. Inoculum preparation and bioreactor cultivation
Pleurotus ostreatus was initially grown on PDA medium in a petri dish for 14
days at 28°C. The surface mycelia with spores were harvested in sterile saline
solution and used as inoculum. Cells were gently homogenized to prevent
the formation of large aggregates in submerged culture. Inoculum for biore-
actor was in form of 50 ml (mycelium-spore) suspension with optical densi-
ty (O.D.) of 1.0 at 600 nm Cultivation was carried out in a 3 L stirred tank
bioreactor Bioflow III (New Brunswick Scientific Co., New Brunswick, NJ,
USA) with a working volume of 2,0 L. Agitation was performed using a
three 4-bladed rushton turbine impellers (di(impeller diameter) = 65 mm; dt(tank diame-
ter) = 135 mm, didt-1 = 0.48) at 400 rpm. Aeration was performed by filtered
sterile air [1 v/v×m]. Dissolved oxygen concentrations were analyzed by po-
larographic electrode (Ingold, Germany). Foam was suppressed, when neces-
sary, by the addition of silicon antifoam reagent (Fluka, Switzerland).
2.4. Analysis
2.4.1. Sample preparation and cell dry weight determination
During cultivation in bioreactor, aliquots (in form of 10-15 ml) of the culture
were taken from the bioreactor vessel through a sampling system. Samples
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were collected in pre-weighed centrifugation tube of 15 ml (Falcon, USA),
centrifuged at 4°C with 5000 rpm for 20 min. Supernatant was frozen at -20
°C for sugar and EPS determination. The cell pellets were washed twice by
distilled water, centrifuged again and dried in oven at 60°C for determination
of cell dry weight.
2.4.2. Determination of glucose
Glucose was determined in the fermentation media by enzymatic method
using a glucose determination kit (Glucose kit Cat. No. 4611, Biocon Diag-
nostic GmbH, Burbach, Germany).
2.4.3. Extraction of polysaccharide from mycelial culture
After sample centrifugation, the resulting culture filtrate was mixed with
equal volume of absolute ethanol, stirred vigorously and kept overnight at
4°C. The precipitate exo-biopolymer was centrifuged at 10.000g for 20 min.
discarding the supernatant (Bae et al. 2000). The precipitate of pure EPS was
washed separately with ethanol, acetone and ethyl ether then lyophilized.
2.4.4. IR spectrometry
Finely ground solid polysaccharide samples compressed with potassium bro-
mide (KBr) into the form of a thin tablet then placed directly into the sam-
ple beam of the spectrometer and the absorption of the spectrum was meas-
ured.
2.4.5. 13C NMR spectrometry
The experiment was done according to the method described by Barrett-Bee
et al. (1982). The polysaccharide sample 50 mg was dissolved in one ml of
concentrated dimethyl sulphoxide (DMSO) by ultrasonic for 10 minutes.
The solution was introduced into a procession ground tube then subjected to
measurement.
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2.5. Cytotoxicity Determination
2.5.1. Cell culture
Oesophageal cancer cell line was routinely maintained at 37°C, 5% CO2.
Cells were cultured in DMEM supplemented with 10% fetal calf serum, 100
U ml-1 penicillin and 100 µg ml-1 streptomycin.
2.5.2. Crystal violet assay
Initial screening of mycelial polysaccharide for cytotoxic activity was carried
out by means of crystal violet staining of treated cells (Saotome et al., 1989).
Oesophageal cancer cells were plated (1,500 cell/well) in 96 well tissue cul-
ture plate. After 24 hour incubation, polysaccharide was added in different
concentrations (50-1000µg ml-1). Following 48 hours incubation, observa-
tion of cell number and morphology were made and the plates were then
processed for staining. Media were discarded; the plates allowed to dray and
100 µl absolute Methanol was applied to each well for 10 minutes. Methanol
was discarded and replaced with staining solution for 20 minutes. Plates were
rinsed with water and 100 µl of water was added to each well for 1 hour. The
water was discarded and replaced with further 100 µl water. Plate was read at
595 nm on micro-plate reader.
2.5.3. Detection of immune stimulation activity of Mushroom
ploysaccharides
Peripheral blood mononuclear cells (PBMC) were isolated from healthy in-
dividual by Ficoll-Hypaque (Sigma, St. Louis, MO, USA) gradient centrifu-
gation. The purified cells was cultured at 1.0×106 cell ml-1 in RPMI 1640
medium (Cambrex, Verviers, Belgium) supplemented with 25mM N-2-hy-
droxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES) (Sigma), 4mM L-
glutamine (Cambrex), 100 U of penicillin and 100 μg streptomycin (Cam-
brex) and 10% FBS (GEBCO, BRL, USA). PBMC were stimulated with
200, 100, 80, 40, and 20 μg ml-1, of each of P. ostreatus mycelia exo-polysac-
charids. All samples were assayed in triplicates. A positive control culture
was included, where PBMC was stimulated with 2 μg ml-1 Phytohemagglu-
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tinin-L (PHA, Sigma). Proliferation was determined after incubation for 3
days at 37ºC, 5% CO2, and 95% humidity, by addition of 201 of BrdU la-
belling reagent (Roche, Penzerg, Germany) in the last 2 hours of the culture.
The labelled cultures were harvested and the BrdU uptake was determined
using Cell Proliferation ELISA, BrdU (colorimetric) kit (Roche) following
the manufacturer instructions. Data were presented as stimulation index (SI),
where proliferation is considered positive if SI is ≥ 2.
3. Results and Discussion
3.1. Cell growth and EPS production in stirred tank bioreactor
Cultivations were carried out in 3 L stirred tank bioreactor to investigate the
kinetics of cell growth and EPS production. As shown in figure (1), cells
grew exponentially during the first 216 h with growth rate of 0.009 [h-1] and
reached a cell mass of 4.7 g l-1. After this time, cell mass kept more or less
constant for the rest of cultivation time. During this phase, the glucose con-
sumption rate was 0.054 [g l-1 h-1] and reduced to 0.021 [g l-1 h-1] as the cells
entered the stationary growth phase. Thus, glucose was not the growth lim-
iting substrate in this process. On the other hand, EPS production started af-
ter 48 h and produced with rate of 0.0063 [g l-1 h-1], reaching the maximal
value of about 1.6 g l-1 after 312 h. Thus, the production of EPS was not
stopped as the cells entered the stationary phase. The data of dissolved oxy-
gen [DO] clearly demonstrate also that during the exponential growth phase
there was significant drop in DO value and increased again at the early sta-
tionary phase.
During exponential growth phase, the pH decreased gradually and
reached about 3.5 after 144 h and increased with very low rate reaching only
3.8 at the end of cultivation. This drop in pH is assumed to be responsible
for growth limitation in culture since neither carbon nor oxygen limitations
were observed in this culture. The decrease in pH of culture medium during
Pleurotus growth might be probably due to production of organic acids as
suggested by Rajarathnam et al. (1992).
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3.2. Structure of isolated polysaccharide
The infrared spectrum of mycelial polysaccharide in Figure 2 indicates the
presence of hydroxyl group which lies in the region between 3200-3600 cm
while the band at 2900 is characteristic to C-H group as well, the IR spec-
trum shows finger print at 860 cm which lies in the anomeric region indicat-
ing the presence of a beta glucosidic bond. On the other hand, 13C NMR
spectrum of mycelial polysaccharide exhibited signals at different resonance
which indicated that the basic structure of the isolated polysaccharide is glu-
can with different linkages mainly 1-3, 1-6 (Figure 3).
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Figure 1. Cell growth and EPS
production during submerged
cultivation of P. ostreatus in 3 L
stirred tank bioreactor.
The NMR spectral features of mycelial polysaccharide of P.ostreatus are
very similar to polysaccharides isolated from different types of mushrooms
such as Lentinus edodes, Grifola frondosa and Ganoderma tsugae (Mizuno et al.,
1992; Zhuang et al., 1992; Zhang et al., 1994). Although, there are signifi-
cant differences in the relative intensities of peaks, reflecting the differences
in the extent of branching.
3.3. Antitumour activity of
mycelial polysaccharide
Polysaccharide isolated from
mycelial culture broth was tested
at different concentration and the
results of crystal violet assay are
presented as absorbance at 595
nm of treated and untreated cells
(figure 4). In principle, an active
compound could cause a decrease
in cell number and hence ab-
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Figure 2. IR spectra of EPS
produced by P. ostreatus in
submerged culture.
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Figure 3. NMR spectra of EPS produced by P. ostreatus
in submerged culture
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sorbance with increasing drug concentration. The results indicate that the
polysaccharide at 250, 500 and 1000 µg ml-1 have a direct cytotoxic effect
against oesophageal cancer cell line. While doses of 50 and 100 µg ml-1
showed to have no cytotoxic effect on the cancer cell line. These data agrees
with the data previously reported indicating that antitumour mushrom poly-
saccharides such as lentinan and schizophyllan showed no direct cyotoxicity
to tumour cell lines in vitro (Aoyagi et al., 1994). On the other hand, poly-
saccharide krestin and polysaccharopeptide PSP isolated from Coriolus versi-
color mushroom had direct cytotoxicity to a wide range of tumor cell lines
(Tsukagoshi et al., 1984 and Yang et al., 1992). We realize that that the poly-
saccharide did not fully enter into solution and sometimes even could in-
creased absorbance reading because the precipitate contributed to the ab-
sorbance for this reason all cells were carefully examined microscopically
prior to staining to determine the presence of precipitates and also to esti-
mate cell density.
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Figure 4. Cytotoxic activity of EPS of mushroom cells on Oseophygus cancer cell line.
3.4. Immunostimulatory effect of EPS
Several studies indicate that some natural mushroom (basidiomycete) prod-
ucts showed to have immuno-potentiating properties which generate consid-
erable interest as possible pharmacological tumoricidal activity (Fujimiya et
al., 1998). Also it was reported that the (1→3)-branched (1→6)-ß –glucan,
termed D-Fraction, extracted from the fruit body of the maitake mushroom
(Grifola frondosa) can enhance the activity of immunocompetent cells such as
macrophages, helper T cells, and cytotoxic T cells to attack tumour cells (Ko-
dama et al., 2002). These findings support our data which is presented in fig-
ure 5 and showed that EPS of the mushroom strain P. ostreatus can stimulate
proliferative response of normal PBMC in a dose independent manner.
4. Conclusion
The results in this work clearly indicated that mycelial exo-polysaccharide
(EPS) isolated from P. ostreatus culture broth seems to have anticancer activ-
ity that is host mediated and cytocidal. Further in vivo experiments will be
carried out to ascertain the anti-tumour effect. Although the mode of cyto-
toxicity of the polysaccharides is still unknown, attempts will be made to ex-
amine and investigate the direct inhibition of RNA, DNA and protein syn-
thesis as well as induction of specific functions of the immune system
including macrophages, T-cells and natural killer cells. The confirmation of
the curative effect of polysaccharides to cancer would be of great interest
both to the nutraceutical industry and to the medical field. These facts gives
a basis to opinion of many researchers in the field that sustainable develop-
ment of mushroom and their products in the 21st century can become a non
–green revolution in natural products medicine.
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Figure 5. Stimulatory effect of different concentration of P. ostreatus EPS on normal
PBMC. Data were presented as stimulation index (SI), where proliferation is considered
positive if SI is ≥ 2.
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